U.S., Oct. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07854249) titled 'A Study to Evaluate the Pharmacokinetics and Safety of INCB161734 in Participants With Impaired Renal Function and Participants on Hemodialysis' on Sept. 28.
Brief Summary: This study is conducted to evaluate the pharmacokinetics and safety of INCB161734 in participants with impaired renal function and participants on hemodialysis.
Study Start Date: Oct. 26
Study Type: INTERVENTIONAL
Condition:
Renal Insufficiency
Kidney Diseases
Intervention:
DRUG: INCB161734
single dose administered orally
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Incyte Corporation
Disclaimer: Curated by HT Syndication....